Page last updated: 2024-10-24

carvedilol and Prostatism

carvedilol has been researched along with Prostatism in 2 studies

Prostatism: Lower urinary tract symptom, such as slow urinary stream, associated with PROSTATIC HYPERPLASIA in older men.

Research Excerpts

ExcerptRelevanceReference
"Carvedilol, compared with enalapril, has a positive influence on LUTS related to BPH in patients with hypertension."9.17Beneficial influence of carvedilol on urologic indices in patients with hypertension and benign prostatic hyperplasia: results of a randomized, crossover study. ( Gaciong, Z; Judycki, J; Korecki, J; Lewandowski, J; Możeńska, O; Rogowski, K; Sieczych, A; Sinski, M; Symonides, B, 2013)
"Carvedilol, compared with enalapril, has a positive influence on LUTS related to BPH in patients with hypertension."5.17Beneficial influence of carvedilol on urologic indices in patients with hypertension and benign prostatic hyperplasia: results of a randomized, crossover study. ( Gaciong, Z; Judycki, J; Korecki, J; Lewandowski, J; Możeńska, O; Rogowski, K; Sieczych, A; Sinski, M; Symonides, B, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lewandowski, J1
Sinski, M1
Symonides, B1
Korecki, J1
Rogowski, K1
Judycki, J1
Sieczych, A1
Możeńska, O1
Gaciong, Z1
Woo, HH1

Trials

1 trial available for carvedilol and Prostatism

ArticleYear
Beneficial influence of carvedilol on urologic indices in patients with hypertension and benign prostatic hyperplasia: results of a randomized, crossover study.
    Urology, 2013, Volume: 82, Issue:3

    Topics: Aged; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Cross-Over Studies; Double-Bl

2013

Other Studies

1 other study available for carvedilol and Prostatism

ArticleYear
Editorial comment.
    Urology, 2013, Volume: 82, Issue:3

    Topics: Antihypertensive Agents; Carbazoles; Carvedilol; Enalapril; Humans; Hypertension; Male; Propanolamin

2013